Captrust Financial Advisors Acadia Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $442,406 - $676,383	-21,290 Reduced 32.53%	44,164 $1.38 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $35,115 - $56,396	1,685 Added 2.64%	65,454 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $1.14 Million - $1.64 Million	63,769 New	63,769 $1.53 Million
Q2 2022 Aug 23, 2022	SELL	$13.01 - $27.22 $988 - $2,068	-76 Reduced 6.74%	1,051 $15,000
Q2 2022 Aug 16, 2022	SELL	$13.01 - $27.22 $13,751 - $28,771	-1,057 Reduced 48.4%	1,127 $16,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $2,156 - $2,832	103 Added 4.95%	2,184 $53,000
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $21,289 - $34,350	1,268 Added 155.97%	2,081 $49,000
Q3 2021 Nov 16, 2021	SELL	$15.78 - $24.77 $21,792 - $34,207	-1,381 Reduced 62.94%	813 $14,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $6,770 - $9,569	-349 Reduced 13.72%	2,194 $54,000
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $18,965 - $41,682	758 Added 42.46%	2,543 $66,000
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $73,256 - $101,370	1,785 New	1,785 $95,000
Q3 2020 Nov 17, 2020	SELL	$36.42 - $57.0 $5,463 - $8,550	-150 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $5,889 - $7,909	150 New	150 $8,000
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $7,777 - $15,403	-350 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $5,255 - $8,411	-367 Reduced 51.19%	350 $6,000
Q3 2018 Nov 15, 2018	SELL	$13.03 - $21.81 $3,882 - $6,499	-298 Reduced 29.36%	717 $15,000
Q2 2018 Aug 13, 2018	BUY	$15.07 - $22.34 $8,514 - $12,622	565 Added 125.56%	1,015 $15,000
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $2,247 - $3,233	-100 Reduced 18.18%	450 $9,000
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $5,368 - $7,828	200 Added 57.14%	550 $17,000
Q3 2017 Feb 16, 2018	BUY	$29.49 - $38.37 $10,321 - $13,429	350	350 $10,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account